OPKO Health (OPK) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Opko Health (OPK) PT Lowered to $8 at Jefferies Following 4Q Miss
March 2, 2017 7:38 AM ESTJefferies lowered its price target on Opko Health (NASDAQ: OPK) to $8.00 (from $10.00) while maintaining a Hold rating. 4Q revenues of $275M came in well below consensus estimates, mainly on weaker BRLI trends.
Analyst Brandon Couillard commented, "4Q16 revenues came in well below... More
